ON funding: not just public / private / pharma / charity
but it would be useful to be able to filter
- major public funding body (eg. NIHR, MRC)
- minor public funding (eg. University)
Bw
Liz
Quoting José Miguel Dora <[log in to unmask]>:
> - recruitment starting date
> - date of closure
> - date of publication
> - sex (male, female or mixed)
>
> Best regards,
> Miguel
>
> Enviado via iPad
>
> Em 10/02/2011, às 19:50, Jim Walker <[log in to unmask]> escreveu:
>
> > Prevention
> > Diagnosis
> > Prognosis
> > Treatment
> >
> >
> > Jim
> >
> > James M. Walker, MD, FACP
> > Chief Health Information Officer
> > Geisinger Health System
> >
> >
> >>>> Nino Cartabellotta <[log in to unmask]> 2/10/2011 12:10 PM >>>
> > Funding:
> > - Public
> > - Private
> > - Mixed
> >
> > Regards
> > Nino Cartabellotta
> > Director of GIMBE
> >
> > Da: Evidence based health (EBH)
> > [mailto:[log in to unmask]] Per conto di Jon
> > Brassey
> > Inviato: giovedì 10 febbraio 2011 18:02
> > A: [log in to unmask]
> > Oggetto: Clinical trials
> >
> > Hi All,
> >
> > We're currently planning the next upgrade to TRIP
> > (www.tripdatabase.com<http://www.tripdatabase.com/>) and we are
> > keen to add access to a clinical trails registry. We have access to the
> > data from one of a major players and the issue we're now faced with are
> > what features do people think would be useful when searching? A few
> > ideas include:
> >
> >
> > * A geographic filter
> > * What stage of recruiting are they at
> > * What type of study (phase 1, 2 etc)
> > * Age range
> > But can anyone suggest others we should consider?
> >
> > Also, if you have any other suggestions to improve TRIP then please let
> > me know.
> >
> > Best wishes
> >
> > jon
> >
> >
> > IMPORTANT WARNING: The information in this message (and the documents
> attached to it, if any) is confidential and may be legally privileged. It is
> intended solely for the addressee. Access to this message by anyone else is
> unauthorized. If you are not the intended recipient, any disclosure, copying,
> distribution or any action taken, or omitted to be taken, in reliance on it
> is prohibited and may be unlawful. If you have received this message in
> error, please delete all electronic copies of this message (and the documents
> attached to it, if any), destroy any hard copies you may have created and
> notify me immediately by replying to this email. Thank you.
>
--
|